Laurie Keating, SVP, GC & Secretary at ALNYLAM PHARMACEUTICALS, INC. (ALKS), sold 10,298 shares at $121.67 ($1.2M) on 2017-12-20, disclosed to the SEC on 2017-12-21.
Open-market sale of $1.2M ALKS by SVP, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.88 | 4,049 | $489K | 39.3% |
| 2 | $120.88 | 4,049 | $489K | 39.3% |
| 3 | $121.67 | 1,900 | $231K | 18.5% |
| 4 | $122.53 | 300 | $37K | 2.9% |
| Total | $121.07 avg | 10,298 | $1.2M | 100% |
| Filing → |
| ALNY | SELL | 2021-08-09 | $1.9M | — | Filing → |
| IMRX | BUY | 2021-08-04 | $105K | — | Filing → |
| ALNY | SELL | 2021-07-14 | $1.2M | — | Filing → |